Comparison of 18F-fluorodeoxyglucose Positron Emission Tomography and Coronary Computed Tomography in Assessing Vascular Inflammation
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for identifying and quantifying vascular inflammation within atherosclerotic plaques.cardiac multidetector-row CT can provide measurements of coronary artery calcium (CAC), the degree of stenosis, and the characteristics of plaque including its potential vulnerability. Therefore, the purpose of the investigators study is to compare the usefulness of 18 FDG-PET and MDCT in assessing the vascular inflammatory status and vulnerability.
| Condition | Intervention |
|---|---|
|
Atherosclerosis |
Other: Cross section study |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Comparison of 18F-fluorodeoxyglucose Positron Emission Tomography and Coronary Computed Tomography in Assessing Vascular Inflammation in Healthy Population |
- Correlation between vascular inflammatory status measured by 18FDG PET and MDCT [ Time Frame: 20weeks ] [ Designated as safety issue: No ]
- Comparison the correlation with inflammatory marker and vascular inflammatory status assessed by 18FDG PET and MDCT [ Time Frame: 20 weeks ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
plasam and serum
| Estimated Enrollment: | 120 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | August 2011 |
| Estimated Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Healthy patients |
Other: Cross section study
This is not intervention study. The purpose of the study is to examine the relationship of vascular inflammation assessed by 18FDG-PET and MDCT at the cross section setting
|
Eligibility| Ages Eligible for Study: | 20 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Healthy participants who underwent a medical health check in the health promotion center in Korea Guro University
Inclusion Criteria:
- Healthy patients for visiting routine medical check in our clinic
Exclusion Criteria:
- History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
- Diabetes
- Stage 2 hypertension (resting blood pressure, ≥ 160/100 mmHg)
- Malignancy
- Severe renal or hepatic disease
- Subjects taking medications that might affect inflammation such as NSIAD and statin
Contacts and Locations| Contact: Hye Jin Yoo, MD | 82-2-2626-3045 | deisy21@medimail.co.kr |
| Korea, Republic of | |
| Hye Jin Yoo | Recruiting |
| Seoul, Korea, Republic of | |
| Contact: Hye Jin Yoo, MD.PhD 82226263045 deisy21@medimail.co.kr | |
| Contact: Kyung Mook Choi, MD.PhD 82226263043 medica7@gmail.com | |
| Principal Investigator: | Kyung Mook Choi, MD.PhD | Korea University |
More Information
No publications provided
| Responsible Party: | Kyung Mook Choi, Korea University |
| ClinicalTrials.gov Identifier: | NCT01100671 History of Changes |
| Other Study ID Numbers: | PET_Coronary CT |
| Study First Received: | April 8, 2010 |
| Last Updated: | June 23, 2011 |
| Health Authority: | South Korea: Institutional Review Board |
Keywords provided by Korea University:
|
atherosclerosis vascular inflammation MDCT 18FDG-PET |
Additional relevant MeSH terms:
|
Atherosclerosis Inflammation Arteriosclerosis Arterial Occlusive Diseases |
Vascular Diseases Cardiovascular Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013